WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China Emerges as Credible Challenger to US in ... (1/21/2026)

China Biopharma Innovation Takes Center Stage ... (1/17/2026)

China Biopharma Sees Record Financing and Lice... (1/13/2026)

China's 2025 Foreign Investment Catalogue Unlo... (1/13/2026)

China's Biopharma Sector Sets New Record for I... (1/12/2026)

China's Innovative Drug Licensing Deals Reach ... (1/12/2026)

Asia Emerges as the New Epicenter of Global Bi... (1/8/2026)

Chinese Drug Makers Hit Record US$136B in Glob... (1/8/2026)

China Biopharma Approvals Surge in December as... (1/6/2026)

China Vital to Insilico's Plan to Build Biotec... (1/4/2026)

China's Beautiful Biotech Chaos vs West's Eleg... (12/30/2025)

China Leads Globally in mRNA-Based Therapeutic... (12/27/2025)

China Launches Clinical Trial of First A... (1/21/2026) Pomdoctor Deepens Pharma Partnerships to... (1/21/2026) CDE Issues Draft Guidance on Using Bayes... (1/21/2026) Roche Advances Oral GLP-1 Program as RO7... (1/21/2026) Pfizer Pulls Back on Mesothelin-Targetin... (1/21/2026) NewDEL Raises A+ Round Led by XtalPi to ... (1/21/2026) Telix Advances China Strategy as Prostat... (1/21/2026) Harbour BioMed Takes Strategic Stake in ... (1/21/2026) Hybio Wins CNY 180M GLP-1 API Order as N... (1/20/2026) Ellipses In-Licenses First-in-Class B7H3... (1/20/2026) Insilico and Hygtia Therapeutics Forge G... (1/20/2026) GSK to Buy RAPT Thera for $2.2B, Securin... (1/20/2026) NMPA Announces Adoption of ICH Q8/Q9/Q10... (1/19/2026) Biyo Secures ~CNY 100M in Pre-A Funding ... (1/19/2026) ABM Thera Licenses MEK1/2 Inhibitor ABM-... (1/19/2026) Henlius Biotech Secures Global Rights to... (1/19/2026) AstraZeneca Acquires Full Global Rights ... (1/19/2026) Recent Executive Moves (1/17/2026)

China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B...

Harbour BioMed Takes Strategic Stake in Spruce Bioscien... NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-... GSK to Buy RAPT Thera for $2.2B, Securing China-Partner... Insilico and Hygtia Therapeutics Forge Global Alliance ... Ellipses In-Licenses First-in-Class B7H3 ADC from China...

CDE Issues Draft Guidance on Using Bayesian External Da... NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guide... China's NMPA to Mandate eCTD Submission Starting March ... China Issues New Procedures for Post-Approval Filing Ch... NHSA Seeks Comments on Draft Rules for Early Communicat...

Pomdoctor Deepens Pharma Partnerships to Drive Internet... NHSA Seeks Feedback on Draft Guidelines for Real-World... China Expands Cross-Province Use of Employee BMI Funds ... China Rolls Out Smart Medical Insurance Payments to Imp... China Convenes National Health Work Conference to Outli...

China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

Telix Advances China Strategy as Prostate Cancer Imagin... Pfizer Pulls Back on Mesothelin-Targeting ADC Sublicens... Roche Advances Oral GLP-1 Program as RO7795081 Cleared ... China Launches Clinical Trial of First Acne Vaccine Can... Sanofi Gains Approval for Two Innovative Therapies in C...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves China Moves to Prosecute Former Traditional Medicine Re...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...